Mode
Text Size
Log in / Sign up
N/A N=92 Randomized Supportive Care

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

Post-operative Complications · Surgical Site Infection · Surgical Wound Infection

Enrolled (actual)
92
Serious AEs
6.5%
Results posted
Aug 2014
Primary outcome: Primary: Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery. — 7; 2 participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Prevena™ Incision Management System (PIMS) (Device); Standard-of-care Dressing (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
KCI USA, Inc
Primary completion
Dec 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.
7; 2
SECONDARY
Incidence Rate of Surgical Incision Intervention (SII) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.
6; 1

Summary

The purpose of this study is to compare the post-surgical standard-of-care dressing to the Prevena™ Incision Management System in women undergoing Cesarean section surgery.

Eligibility Criteria

Inclusion Criteria

The Subject:

  • is a female aged ≥ 18 years
  • is able to provide her own informed consent
  • will undergo a Cesarean section procedure using a subcuticular skin closure technique within the next 42 days
  • will require a surgical incision able to be covered completely by the PIMS skin interface
  • has a BMI ≥ 35 kg/m2 as determined during the Screening Period up to 42 days pre-surgery
  • is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
  • Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered
  • OR -
  • Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination
  • is willing and able to return for all scheduled and required study visits
  • is not concurrently enrolled in another clinical intervention trial which may impact maternal health or the surgical site

Exclusion Criteria

The Subject:

  • is ASA Class P4, P5, or P6 (Appendix F - American Society of Anesthesiologists (ASA) Physical Status Classification System)
  • has a systemic bacterial or fungal infection at the time of surgery
  • has a remote-site skin infection at the time of surgery
  • has a life expectancy of < 12 months
  • is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
  • Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
  • OR -
  • Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
  • experiences intraoperative hemorrhage requiring transfusion, disseminated-intravascular coagulopathy (DIC) or other medical or surgical condition during the Cesarean section deemed by the investigator to pose a prohibitively high risk for surgical re-exploration
  • who, in the investigator's opinion, would have any clinically significant condition that would impair the participant's ability to comply with the study procedures
  • has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01450631). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search